RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: APOE ε4 and peripheral metabolic network architecture in older adults

J Alzheimers Dis 113(3):1335-1346 · 2026 · PMID 42663443

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

1,511편 검색→1,486편 판독→346편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Apolipoprotein E4 genotype and peripheral metabolic biomarkers such as lipids, homocysteine and vitamin D in cognitive impairment (("apolipoprotein E4"[tiab] OR "APOE4"[tiab] OR "APOE ε4"[tiab] OR "APOE e4"[tiab] OR "apoE4"[tiab] OR "APOE genotype"[tiab] OR "apolipoprotein E genotype"[tiab] OR "ApoE allele"[tiab]) AND (lipid*[tiab] OR cholesterol[tiab] OR triglyceride*[tiab] OR homocysteine[tiab] OR "vitamin D"[tiab] OR "25-hydroxyvitamin D"[tiab] OR "metabolic biomarker*"[tiab] OR "peripheral biomarker*"[tiab]) AND (cognitive impairment[tiab] OR "cognitive decline"[tiab] OR dementia[tiab] OR "Alzheimer disease"[tiab] OR "mild cognitive impairment"[tiab] OR "cognitive dysfunction"[tiab]))

출판 연도

1994: 1편119941995: 1편11996: 2편21997: 3편31998: 3편31999: 4편42000: 7편720002001: 7편72002: 6편62003: 6편62004: 4편42005: 6편620052006: 8편82007: 8편82008: 6편62009: 6편62010: 10편1020102011: 11편112012: 11편112013: 10편102014: 9편92015: 7편720152016: 9편92017: 15편152018: 11편112019: 16편162020: 20편2020202021: 16편162022: 17편172023: 24편242024: 17편172025: 30편302026: 35편352026

선별된 346편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01mild · decline93편

  1. 0.92

    Homocysteine and cognitive performance: modification by the ApoE genotype

    Elias MF, Robbins MA, Budge MM et al. · Neuroscience letters · 2008

  2. 0.91

    Longitudinal associations between lipid panel and cognitive decline modified by APOE 4 carrier status in biracial community-dwelling older adults: Findings from the Chicago health and aging project

    Ng TKS, Beck T, Liu X et al. · Archives of gerontology and geriatrics · 2025

  3. 0.90

    Associations of one-carbon metabolism, related B-vitamins and ApoE genotype with cognitive function in older adults: identification of a novel gene-nutrient interaction

    Gordon S, Hoey L, McNulty H et al. · BMC medicine · 2025

  4. 0.90

    Association of ApoE epsilon4 allele, homocysteine, and inflammatory factors (hs-CRP, IL-6, TNF-alpha) with cognitive dysfunction in Alzheimer's disease patients and development and validation of a predictive model

    Wang L, Sun Q · Neurological research · 2026

  5. 0.90

    Do the effects of APOE-epsilon4 on cognitive function and decline depend upon vitamin status? MacArthur Studies of Successful Aging

    Brown B, Huang MH, Karlamangla A et al. · The journal of nutrition, health & aging · 2011

  6. 0.89

    Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative

    Dunk MM, Driscoll I · Journal of Alzheimer's disease : JAD · 2022

  7. 0.89

    Relationship between the diagnostic components of metabolic syndrome (MS) and cognition by ApoE genotype in the elderly

    Lee KS, Jang Y, Chung YK et al. · Archives of gerontology and geriatrics · 2010

  8. 0.89

    Insulin resistance (TyG index) and body mass index as metabolic biomarker combined with ApoE genotype to diagnose Alzheimer's disease

    Chen R, Fan S, Di C et al. · Frontiers in aging neuroscience · 2026

  9. 0.89

    Association of Homocysteine Levels With Medial Temporal Lobe Atrophy Among Carriers and Non-carriers of APOE epsilon4 in MCI Subjects

    Ma J, Ma LY, Man F et al. · Frontiers in psychiatry · 2022

  10. 0.89

    Conversion from MCI to AD in patients with the APOE epsilon4 genotype: Prediction by plasma HCY and serum BDNF

    Zheng L, Kong X, Cui Y et al. · Neuroscience letters · 2016

  11. 0.88

    High homocysteine and epistasis between MTHFR and APOE: association with cognitive performance in the elderly

    Polito L, Poloni TE, Vaccaro R et al. · Experimental gerontology · 2016

  12. 0.88

    Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype Are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease

    Supasitthumrong T, Tunvirachaisakul C, Aniwattanapong D et al. · Journal of Alzheimer's disease : JAD · 2019

  13. 0.88

    Homocysteine, neurodegenerative biomarkers, and APOE epsilon4 in neurodegenerative diseases

    Lin WZ, Yu D, Xiong LY et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  14. 0.88

    The Apolipoprotein E epsilon4 Allele-Dependent Relationship Between Serum Lipid Levels and Cognitive Function: A Population-Based Cross-sectional Study

    Wei S, Gao L, Jiang Y et al. · Frontiers in aging neuroscience · 2020

  15. 0.87

    Components of the choline oxidation pathway modify the association between the apolipoprotein epsilon4 gene variant and cognitive decline in patients with dementia

    Hildre AS, Solvang SEH, Aarsland D et al. · Brain research · 2020

  16. 0.87

    Association between vitamin A, vitamin E and apolipoprotein E status with mild cognitive impairment among elderly people in low-cost residential areas

    Shahar S, Lee LK, Rajab N et al. · Nutritional neuroscience · 2013

  17. 0.87

    Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype

    Yasuno F, Tanimukai S, Sasaki M et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2012

  18. 0.87

    Effect of plasma lipids and APOE genotype on cognitive decline

    Yasuno F, Asada T · Dialogues in clinical neuroscience · 2013

  19. 0.86

    The Association Between Homocysteine and Memory in Older Adults

    Nelson ME, Andel R, Nedelska Z et al. · Journal of Alzheimer's disease : JAD · 2021

  20. 0.86

    Apolipoprotein E Induced Cognitive Dysfunction: Mediation Analysis of Lipids and Glucose Biomarkers in an Elderly Cohort Study

    Liu L, Li H, Iyer H et al. · Frontiers in aging neuroscience · 2021

  21. 0.86

    APOE epsilon4 and peripheral metabolic network architecture in older adults 이 논문

    Oh DJ, Han JW, Kim TH et al. · Journal of Alzheimer's disease : JAD · 2026

  22. 0.86

    Effect of plasma lipids, hypertension and APOE genotype on cognitive decline

    Yasuno F, Tanimukai S, Sasaki M et al. · Neurobiology of aging · 2012

  23. 0.86

    The role of extracerebral cholesterol homeostasis and ApoE e4 in cognitive decline

    van den Kommer TN, Dik MG, Comijs HC et al. · Neurobiology of aging · 2012

  24. 0.85

    Longitudinal lipid profile variations and clinical change in Alzheimer's disease dementia

    de Oliveira FF, Chen ES, Smith MC et al. · Neuroscience letters · 2017

  25. 0.85

    Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease

    Karim R, Koc M, Rettberg JR et al. · Menopause (New York, N.Y.) · 2019

  26. 0.85

    Cholesterol and APOE genotype interact to influence Alzheimer disease progression

    Evans RM, Hui S, Perkins A et al. · Neurology · 2004

  27. 0.84

    Subjective memory complaints with and without objective memory impairment: relationship with risk factors for dementia

    Lautenschlager NT, Flicker L, Vasikaran S et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2005

  28. 0.83

    Risk profiles of subtypes of mild cognitive impairment: the sydney memory and ageing study

    Sachdev PS, Lipnicki DM, Crawford J et al. · Journal of the American Geriatrics Society · 2012

  29. 0.83

    Diminished circulating retinol and elevated alpha-TOH/retinol ratio predict an increased risk of cognitive decline in aging Chinese adults, especially in subjects with ApoE2 or ApoE4 genotype

    Huang X, Zhang H, Zhen J et al. · Aging · 2018

  30. 0.82

    Vitamin D is not associated with cognitive status in a cohort of very old hospitalized patients

    Graf CE, Rossi C, Giannelli SV et al. · Journal of Alzheimer's disease : JAD · 2014

  31. 0.81

    Association of ApoE Genetic Polymorphism and Type 2 Diabetes with Cognition in Non-Demented Aging Chinese Adults: A Community Based Cross-Sectional Study

    Zhen J, Lin T, Huang X et al. · Aging and disease · 2018

  32. 0.81

    Metabolic syndrome, ApoE genotype, and cognitive dysfunction in an elderly population: A single-center, case-control study

    Wang JY, Zhang L, Liu J et al. · World journal of clinical cases · 2021

  33. 0.81

    Vitamin D deficiency may accelerate cognitive decline in female apolipoprotein E epsilon4 non-carriers RECODE

    Kim J, Ji E, Bae JB et al. · Clinical nutrition (Edinburgh, Scotland) · 2025

  34. 0.81

    Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study

    Davidson JE, Lockhart A, Amos L et al. · Alzheimer's research & therapy · 2012

  35. 0.81

    Lipid Trajectories Improve Risk Models for Alzheimer's Disease and Mild Cognitive Impairment

    Chase BA, Frigerio R, Yucus CJ et al. · medRxiv : the preprint server for health sciences · 2024

  36. 0.80

    Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E varepsilon4 Carriers and Adults with Mild Cognitive Impairment

    Hanson AJ, Bayer JL, Baker LD et al. · Journal of Alzheimer's disease : JAD · 2015

  37. 0.80

    Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial

    Sparks DL, Connor DJ, Sabbagh MN et al. · Acta neurologica Scandinavica. Supplementum · 2006

  38. 0.80

    Impact of the Apolipoprotein E epsilon4 Allele on Cognition and Omega-3 Fatty Acid Levels in the Plasma Membrane of Red Blood Cells in Healthy Elderly Japanese Population

    Hashimoto M, Matsuzaki K, Matsuda C et al. · Dementia and geriatric cognitive disorders extra · 2025

  39. 0.79

    Determinants, MRI correlates, and prognosis of mild cognitive impairment: the Rotterdam Study

    de Bruijn RFAG, Akoudad S, Cremers LGM et al. · Journal of Alzheimer's disease : JAD · 2014

  40. 0.79

    Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease

    Wroolie T, Roat-Shumway S, Watson K et al. · Journal of Alzheimer's disease : JAD · 2020

  41. 0.79

    Validation of the Thai version of the short Boston Naming Test (T-BNT) in patients with Alzheimer's dementia and mild cognitive impairment: clinical and biomarker correlates

    Aniwattanapong D, Tangwongchai S, Supasitthumrong T et al. · Aging & mental health · 2019

  42. 0.79

    Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE varepsilon4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease

    Niu X, Wang Y, Zhang X et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024

  43. 0.79

    Relationship Between B-Vitamin Biomarkers and Dietary Intake with Apolipoprotein E small je, Ukrainian4 in Alzheimer's Disease

    D'Cunha NM, Georgousopoulou EN, Boyd L et al. · Journal of nutrition in gerontology and geriatrics · 2019

  44. 0.78

    Effect of Virgin Coconut Oil Supplementation on Cognition of Individuals with Mild-to-Moderate Alzheimer's Disease in Sri Lanka (VCO-AD Study): A Randomized Placebo-Controlled Trial

    Fernando MG, Silva R, Fernando WMADB et al. · Journal of Alzheimer's disease : JAD · 2023

  45. 0.78

    Folate, vitamin b(12), and homocysteine as risk factors for cognitive decline in the elderly

    Kim JM, Kim SW, Shin IS et al. · Psychiatry investigation · 2008

  46. 0.77

    Cadmium-associated cognitive impairment in adults: Proteomics-guided blood-based risk stratification with external validation and rat multimodal corroboration

    Gao H, Liu H, Wan S et al. · Environmental pollution (Barking, Essex : 1987) · 2026

  47. 0.77

    Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years

    Toro P, Degen C, Pierer M et al. · European archives of psychiatry and clinical neuroscience · 2014

  48. 0.77

    Apolipoprotein E and Health in Older Men: The Concord Health and Ageing in Men Project

    Le Couteur DG, Stanaway F, Waite LM et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2020

  49. 0.76

    Cholesterol dysregulation in peripheral blood mononuclear cells of Alzheimer's disease

    Martin-Montes A, Recuero M, Sastre I et al. · Journal of neuroimmunology · 2022

  50. 0.76

    Identification of cognitive impairment in the elderly: homocysteine is an early marker

    Lehmann M, Gottfries CG, Regland B · Dementia and geriatric cognitive disorders · 1999

  51. 0.76

    Longitudinal and nonlinear relations of dietary and Serum cholesterol in midlife with cognitive decline: results from EMCOA study

    An Y, Zhang X, Wang Y et al. · Molecular neurodegeneration · 2019

  52. 0.75

    ApoB, small-dense LDL-C, Lp(a), LpPLA(2) activity, and cognitive change

    Pokharel Y, Mouhanna F, Nambi V et al. · Neurology · 2019

  53. 0.74

    Interaction between arteriosclerosis and the APOE4 gene in cognitive decline in older adults: a cross-sectional study in rural minority areas in western China

    Qu F, Yang X, Yang J et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2022

  54. 0.74

    Sydney Memory and Ageing Study: an epidemiological cohort study of brain ageing and dementia

    Tsang RSM, Sachdev PS, Reppermund S et al. · International review of psychiatry (Abingdon, England) · 2013

  55. 0.74

    From mild cognitive impairment to Alzheimer's disease - influence of homocysteine, vitamin B12 and folate on cognition over time: results from one-year follow-up

    Siuda J, Gorzkowska A, Patalong-Ogiewa M et al. · Neurologia i neurochirurgia polska · 2009

  56. 0.73

    One-carbon metabolism and other biochemical correlates of cognitive impairment as visualized by principal component analysis

    Gottfries J, Blennow K, Lehmann MW et al. · Journal of geriatric psychiatry and neurology · 2001

  57. 0.72

    Cognitive decline is related to high blood glucose levels in older Chinese adults with the ApoE epsilon3/epsilon3 genotype

    Qiu Q, Lin X, Sun L et al. · Translational neurodegeneration · 2019

  58. 0.70

    Lipid trajectories improve risk models for Alzheimer's disease and mild cognitive impairment

    Chase BA, Frigerio R, Yucus CJ et al. · Journal of lipid research · 2025

  59. 0.69

    TNFR-1 and GDF-15 Are Associated With Plasma Neurofilament Light Chain and Progranulin Among Community-Dwelling Older Adults: A Secondary Analysis of the MAPT Study

    Giudici KV, de Souto Barreto P, Guyonnet S et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2023

  60. 0.69

    Apolipoprotein E epsilon4 Allele is Associated With Plasma Amyloid Beta and Amyloid Beta Transporter Levels: A Cross-sectional Study in a Rural Area of Xi'an, China

    Wei S, Gao L, Jiang Y et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2020

  61. 0.66

    Buccal cell cytokeratin 14 identifies mild cognitive impairment and Alzheimer' s disease in the AIBL study of aging

    Leifert WR, Tuli JF, Francois M et al. · Current Alzheimer research · 2015

  62. 0.66

    Interactions Between Blood Nutritional Biomarkers and Apolipoprotein E epsilon4 in the Progression of Mild Cognitive Impairment in Alzheimer's Disease

    Lawal R, Kumar S, Chigevenga R et al. · Nutrients · 2026

  63. 0.65

    The Role of ApoE Polymorphism in the Relationship between Serum Steroid Hormone Levels and Cognition in Older Chinese Adults: A Cross-Sectional Study

    Huang X, Dong S, Zhen J et al. · Frontiers in endocrinology · 2018

  64. 0.65

    Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults

    Miller JW, Harvey DJ, Beckett LA et al. · JAMA neurology · 2015

  65. 0.64

    Does elevated parathyroid hormone concentration predict cognitive decline in older people?

    Bjorkman MP, Sorva AJ, Tilvis RS · Aging clinical and experimental research · 2010

  66. 0.64

    'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function

    Squitti R, Ventriglia M, Barbati G et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2007

  67. 0.63

    Circulating folate concentrations and the risk of mild cognitive impairment: A prospective study on the older Chinese population without folic acid fortification

    Fu J, Liu Q, Zhu Y et al. · European journal of neurology · 2022

  68. 0.62

    Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4(-/-): A double-blind, randomized, placebo-controlled crossover trial

    Xu Q, Zhang Y, Zhang X et al. · Clinical nutrition (Edinburgh, Scotland) · 2020

  69. 0.62

    No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab

    Korthauer LE, Giugliano RP, Guo J et al. · PloS one · 2022

  70. 0.62

    Association of APOE rs405509 (-219 T/G) with multidimensional cognitive function, brain structure, and resting-state networks in Chinese community-dwelling older adults

    Wang Z, Ding J, Hu X et al. · Brain research bulletin · 2026

  71. 0.61

    Associations of Vascular Risk Factors, APOE and TOMM40 Polymorphisms With Cognitive Function in Dementia-Free Chinese Older Adults: A Community-Based Study

    Gui W, Qiu C, Shao Q et al. · Frontiers in psychiatry · 2021

  72. 0.60

    Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men

    Kalmijn S, Feskens EJ, Launer LJ et al. · Stroke · 1996

  73. 0.59

    The contribution of vascular risk factors in neurodegenerative disorders: from mild cognitive impairment to Alzheimer's disease

    Cheng YW, Chiu MJ, Chen YF et al. · Alzheimer's research & therapy · 2020

  74. 0.59

    Association between apolipoprotein E epsilon4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders

    Ma F, Wang J, Miao R et al. · Neuropsychobiology · 2011

  75. 0.58

    An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative

    Samtani MN, Farnum M, Lobanov V et al. · Journal of clinical pharmacology · 2012

  76. 0.58

    IQ, educational attainment, memory and plasma lipids: associations with apolipoprotein E genotype in 5995 children

    Taylor AE, Guthrie PAI, Smith GD et al. · Biological psychiatry · 2011

  77. 0.57

    APOE epsilon4, the door to insulin-resistant dyslipidemia and brain fog? A case study

    Stoykovich S, Gibas K · Alzheimer's & dementia (Amsterdam, Netherlands) · 2019

  78. 0.57

    Relationship of Muscle Apolipoprotein E Expression with Markers of Cellular Stress, Metabolism, and Blood Biomarkers in Cognitively Healthy and Impaired Older Adults

    Johnson CN, McCoin CS, Kueck PJ et al. · Journal of Alzheimer's disease : JAD · 2023

  79. 0.56

    A Genome-Wide Interaction Study of Erythrocyte omega-3 Polyunsaturated Fatty Acid Species and Memory in the Framingham Heart Study Offspring Cohort

    Annevelink CE, Westra J, Sala-Vila A et al. · The Journal of nutrition · 2024

  80. 0.56

    Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E status

    Rockwood K, Howlett S, Fisk J et al. · Neuroepidemiology · 2007

  81. 0.56

    Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging women

    Bates KA, Sohrabi HR, Rainey-Smith SR et al. · The International journal of neuroscience · 2017

  82. 0.56

    Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer's disease

    Gottfries CG, Lehmann W, Regland B · Journal of neural transmission (Vienna, Austria : 1996) · 1998

  83. 0.55

    Differences in the association of peripheral insulin and cognitive function in non-diabetic Alzheimer's disease cases and normal controls

    Pavlik V, Massman P, Barber R et al. · Journal of Alzheimer's disease : JAD · 2013

  84. 0.55

    Ketogenic diet rescues cognition in ApoE4+ patient with mild Alzheimer's disease: A case study

    Morrill SJ, Gibas KJ · Diabetes & metabolic syndrome · 2019

  85. 0.55

    Age- and Sex-Different Associations between Cognitive Performance and Inflammatory Biomarkers in Community Dwelling Older Adults: towards Precision Preventive Strategies

    Chen BA, Lee WJ, Chung CP et al. · The journal of prevention of Alzheimer's disease · 2023

  86. 0.54

    Selenium level is associated with apoE epsilon4 in rural elderly Chinese

    Gao S, Jin Y, Hall KS et al. · Public health nutrition · 2009

  87. 0.52

    Correlation of peripheral olfactomedin 1 with Alzheimer's disease and cognitive functions

    Wei C, Zhang G, Fu X et al. · Translational psychiatry · 2025

  88. 0.52

    The Joint Effects of Life's Essential 8 and Genetics on Mild Cognitive Impairment and Dementia Risk in People With Diabetes: Findings From the UK Biobank and All of Us

    Wu X, Zu Y, Lu Y et al. · Diabetes care · 2026

  89. 0.52

    Homozygosity for the APOE E4 allele is solely associated with lower cognitive performance in Brazilian community-dwelling older adults: the Bambui Study

    Quintino-Santos SR, Lima-Costa MF, Uchoa E et al. · Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) · 2012

  90. 0.51

    The relationship between nutrient intake and cognitive performance in people at risk of dementia

    Salerno-Kennedy R, Cashman KD · Irish journal of medical science · 2007

  91. 0.50

    KIF6 719Arg allele is associated with statin effects on cholesterol levels in amnestic mild cognitive impairment and Alzheimer's disease patients

    Sabbagh M, Malek-Ahmadi M, Levenson I et al. · Journal of Alzheimer's disease : JAD · 2013

  92. 0.50

    Nutritional Ketosis and photobiomodulation remediate mitochondria warding off Alzheimer's disease in a diabetic, ApoE4+ patient with mild cognitive impairment: A case report

    Horner S, Berger L, Gibas K · Photodiagnosis and photodynamic therapy · 2020

  93. 0.50

    Internal Lipid Profile and Body Lipid Profile in Relation to Cognition: A Cross-Sectional Study in Southern China

    Liu L, Huang X, Feng L et al. · American journal of Alzheimer's disease and other dementias · 2020

02dementia · risk factors70편

  1. 0.90

    Medial temporal lobe atrophy, apolipoprotein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer's disease

    de Silva HA, Gunatilake SB, Johnston C et al. · Experimental aging research · 2005

  2. 0.89

    Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba

    Hall K, Murrell J, Ogunniyi A et al. · Neurology · 2006

  3. 0.89

    High-Density Lipoprotein Cholesterol and Cognitive Function in Older Korean Adults Without Dementia: Apolipoprotein E4 as a Moderating Factor

    Choe YM, Choi HJ, Keum M et al. · Nutrients · 2025

  4. 0.89

    Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers

    Gonzalez C, Martin T, Cacho J et al. · European journal of clinical investigation · 1999

  5. 0.87

    Apolipoprotein E genotypes and serum lipid levels in Alzheimer's disease and multi-infarct dementia

    Wieringa GE, Burlinson S, Rafferty JA et al. · International journal of geriatric psychiatry · 1997

  6. 0.87

    Plasma cholesterol in Alzheimer's disease and frontotemporal dementia

    Wang P, Zhang H, Wang Y et al. · Translational neuroscience · 2020

  7. 0.87

    Associations of dietary cholesterol and fat, blood lipids, and risk for dementia in older women vary by APOE genotype

    Dunk MM, Li J, Liu S et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  8. 0.87

    Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

    Notkola IL, Sulkava R, Pekkanen J et al. · Neuroepidemiology · 1998

  9. 0.86

    Apolipoprotein E genotype and lipid and lipoprotein levels in dementia

    Wehr H, Parnowski T, Puzynski S et al. · Dementia and geriatric cognitive disorders · 2000

  10. 0.86

    The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease

    Dupuy AM, Mas E, Ritchie K et al. · Gerontology · 2001

  11. 0.86

    Lipids and adipokines as risk factors for Alzheimer's disease

    Warren MW, Hynan LS, Weiner MF · Journal of Alzheimer's disease : JAD · 2012

  12. 0.85

    APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study

    Dufouil C, Richard F, Fievet N et al. · Neurology · 2005

  13. 0.84

    Plasma oxysterols are associated with serum lipids and dementia risk in older women

    Dunk MM, Rapp SR, Hayden KM et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  14. 0.84

    Ideal vitamin D and handgrip strength counteracts the risk effect of APOE genotype on dementia: a population-based longitudinal study

    Feng J, Wang Q, Zhang Y · Journal of translational medicine · 2023

  15. 0.84

    Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy

    Mukerji SS, Locascio JJ, Misra V et al. · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016

  16. 0.84

    Effects of exercise training on stroke risk factors, homocysteine concentration, and cognitive function according the APOE genotype in stroke patients

    Lee JH, Hong SM, Shin YA · Journal of exercise rehabilitation · 2018

  17. 0.83

    The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging

    Mielke MM, Haughey NJ, Han D et al. · Journal of Alzheimer's disease : JAD · 2017

  18. 0.83

    Plasma homocysteine, apolipoprotein E status and vascular disease in elderly patients with mental illness

    Nilsson K, Gustafson L, Nornholm M et al. · Clinical chemistry and laboratory medicine · 2010

  19. 0.82

    Vitamin D supplementation and incident dementia: Effects of sex, APOE, and baseline cognitive status

    Ghahremani M, Smith EE, Chen HY et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2023

  20. 0.81

    Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia

    Paragh G, Balla P, Katona E et al. · European archives of psychiatry and clinical neuroscience · 2002

  21. 0.81

    Cholesterol and LDL relate to neuritic plaques and to APOE4 presence but not to neurofibrillary tangles

    Lesser GT, Beeri MS, Schmeidler J et al. · Current Alzheimer research · 2011

  22. 0.80

    Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease

    Lesser G, Kandiah K, Libow LS et al. · Dementia and geriatric cognitive disorders · 2001

  23. 0.80

    The relation between apolipoprotein A-I and dementia: the Honolulu-Asia aging study

    Saczynski JS, White L, Peila RL et al. · American journal of epidemiology · 2007

  24. 0.80

    Relation of Serum Plasmalogens and APOE Genotype to Cognition and Dementia in Older Persons in a Cross-Sectional Study

    Goodenowe DB, Senanayake V · Brain sciences · 2019

  25. 0.79

    Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study

    Schilling S, Tzourio C, Soumare A et al. · PLoS medicine · 2017

  26. 0.79

    Serum 25-Hydroxyvitamin D, Vitamin D Receptor, and Vitamin-D-Binding Protein Gene Polymorphisms and Risk of Dementia Among Older Adults With Prediabetes

    Zhou C, Gan X, Ye Z et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2024

  27. 0.78

    Serum 24-hydroxycholesterol in probable Alzheimer's dementia: Reexploring the significance of a tentative Alzheimer's disease biomarker

    Roy D, Chakrabarti SS, Banerjee A et al. · Aging medicine (Milton (N.S.W)) · 2019

  28. 0.78

    Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study

    Bonarek M, Barberger-Gateau P, Letenneur L et al. · Neuroepidemiology · 2000

  29. 0.76

    Total serum cholesterol levels and Alzheimer's dementia in patients with Down syndrome

    Prasher VP, Airuehia E, Patel A et al. · International journal of geriatric psychiatry · 2008

  30. 0.76

    Contribution of vascular risk factors to the progression in Alzheimer disease

    Helzner EP, Luchsinger JA, Scarmeas N et al. · Archives of neurology · 2009

  31. 0.76

    Relationships between heritable dementia risk factors, cardiovascular risk factors in young adulthood, and midlife neuropsychological outcomes

    Koychev I, Vaci N, Moonen J et al. · Journal of Alzheimer's disease : JAD · 2026

  32. 0.75

    Synergistic epistasis of paraoxonase 1 (rs662 and rs85460) and apolipoprotein E4 genes in pathogenesis of Alzheimer's disease and vascular dementia

    Alam R, Tripathi M, Mansoori N et al. · American journal of Alzheimer's disease and other dementias · 2014

  33. 0.75

    Genetic and environmental risk factors for Alzheimer's disease in Israeli Arabs

    Bowirrat A, Friedland RP, Farrer L et al. · Journal of molecular neuroscience : MN · 2002

  34. 0.74

    Red Blood Cell DHA Is Inversely Associated with Risk of Incident Alzheimer's Disease and All-Cause Dementia: Framingham Offspring Study

    Sala-Vila A, Satizabal CL, Tintle N et al. · Nutrients · 2022

  35. 0.74

    Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study

    Kuusisto J, Koivisto K, Mykkanen L et al. · BMJ (Clinical research ed.) · 1997

  36. 0.73

    Associations of modifiable and non-modifiable risk factors with cognitive functions - a prospective, population-based, 17 years follow-up study of 3,229 individuals

    Glans I, Nagga K, Gustavsson AM et al. · Alzheimer's research & therapy · 2024

  37. 0.72

    Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

    Kivipelto M, Helkala EL, Laakso MP et al. · Annals of internal medicine · 2002

  38. 0.71

    Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort Study

    Zhou Z, Ryan J, Tonkin AM et al. · Neurology · 2023

  39. 0.71

    Low serum HDL-cholesterol is associated with increased risk of the subcortical small vessel type of dementia

    Axelsson Andren E, Safi D, Wallin A et al. · Cerebral circulation - cognition and behavior · 2024

  40. 0.71

    Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study

    Akomolafe A, Beiser A, Meigs JB et al. · Archives of neurology · 2006

  41. 0.70

    Apolipoprotein E e4 allele affects risk of hyperhomocysteinemia in the elderly

    Ravaglia G, Forti P, Maioli F et al. · The American journal of clinical nutrition · 2006

  42. 0.69

    Serum noncholesterol sterols in Alzheimer's disease: the Helsinki Businessmen Study

    Sittiwet C, Simonen P, Nissinen MJ et al. · Translational research : the journal of laboratory and clinical medicine · 2018

  43. 0.69

    Association of circulating branched-chain or aromatic amino acids based on metabolome and apolipoprotein E genotype with incident dementia: a large cohort study

    Liu Z, Ai Y, Wu Y et al. · International journal of food sciences and nutrition · 2026

  44. 0.68

    The association between APOE and dementia does not seem to be mediated by vascular factors

    Prince M, Lovestone S, Cervilla J et al. · Neurology · 2000

  45. 0.68

    High cholesterol levels change the association of biomarkers of neurodegenerative diseases with dementia risk: Findings from a population-based cohort

    Perna L, Mons U, Stocker H et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  46. 0.68

    Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study

    Raffaitin C, Gin H, Empana JP et al. · Diabetes care · 2009

  47. 0.67

    Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study

    Tan ZS, Seshadri S, Beiser A et al. · Archives of internal medicine · 2003

  48. 0.66

    Metabolomic ageing (MileAge) in mid-life predicts incident vascular, unspecified and all-cause dementia

    Mutz J, Gilchrist L, Pain O et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  49. 0.64

    Differential subtypes of diabetic older adults diagnosed with Alzheimer's disease

    Sakurai T, Kawashima S, Satake S et al. · Geriatrics & gerontology international · 2014

  50. 0.64

    Exploring the causal effects of serum lipids and lipidomes on lewy body dementia: a Mendelian randomization study

    Fu Q, Pan G, Yu Q et al. · Frontiers in endocrinology · 2024

  51. 0.63

    Serum cholesterol and risk of Alzheimer disease: a community-based cohort study

    Li G, Shofer JB, Kukull WA et al. · Neurology · 2005

  52. 0.63

    Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

    Seshadri S, Beiser A, Selhub J et al. · The New England journal of medicine · 2002

  53. 0.62

    Association of Alzheimer disease pathology with abnormal lipid metabolism: the Hisayama Study

    Matsuzaki T, Sasaki K, Hata J et al. · Neurology · 2011

  54. 0.62

    Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis

    Schmidt AF, Davidson MH, Ditmarsch M et al. · Alzheimer's research & therapy · 2024

  55. 0.59

    Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study

    Solomon A, Kareholt I, Ngandu T et al. · Neurology · 2007

  56. 0.59

    Metabolic Syndrome and Cognitive Impairment among High Socioeconomic, Nondemented Older US Adults

    Martinez-Miller EE, Kohl HW3, Barlow CE et al. · Journal of the American Geriatrics Society · 2019

  57. 0.59

    Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors

    Haan MN, Mungas DM, Gonzalez HM et al. · Journal of the American Geriatrics Society · 2003

  58. 0.59

    Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans

    Hendrie HC, Hake A, Lane K et al. · Ethnicity & disease · 2015

  59. 0.59

    Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study

    Hooshmand B, Solomon A, Kareholt I et al. · Neurology · 2010

  60. 0.58

    Low-density lipoprotein cholesterol and the risk of dementia with stroke

    Moroney JT, Tang MX, Berglund L et al. · JAMA · 1999

  61. 0.58

    The contribution of apolipoprotein E genetic variation to dementia risk in British South Asians

    Jacobs BM, Chandra A, Foote IF et al. · Brain communications · 2026

  62. 0.57

    Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors

    Miwa K, Tanaka M, Okazaki S et al. · Journal of Alzheimer's disease : JAD · 2016

  63. 0.57

    Cholesterol and neuropathologic markers of AD: a population-based autopsy study

    Launer LJ, White LR, Petrovitch H et al. · Neurology · 2001

  64. 0.56

    Metabolic Syndrome Is Associated With Poor Cognition: A Population-Based Study of 70-Year-Old Adults Without Dementia

    Marseglia A, Darin-Mattsson A, Skoog J et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2021

  65. 0.55

    Plasma high-density lipoprotein cholesterol and risk of dementia: observational and genetic studies

    Kjeldsen EW, Thomassen JQ, Juul Rasmussen I et al. · Cardiovascular research · 2022

  66. 0.55

    Homocysteine and folate as risk factors for dementia and Alzheimer disease

    Ravaglia G, Forti P, Maioli F et al. · The American journal of clinical nutrition · 2005

  67. 0.54

    Relation of plasma homocysteine to plasma amyloid beta levels

    Luchsinger JA, Tang MX, Miller J et al. · Neurochemical research · 2007

  68. 0.54

    Triglycerides as a Shared Risk Factor between Dementia and Atherosclerotic Cardiovascular Disease: A Study of 125 727 Individuals

    Nordestgaard LT, Christoffersen M, Afzal S et al. · Clinical chemistry · 2021

  69. 0.54

    Association of dietary cholesterol and egg intakes with the risk of incident dementia or Alzheimer disease: the Kuopio Ischaemic Heart Disease Risk Factor Study

    Ylilauri MP, Voutilainen S, Lonnroos E et al. · The American journal of clinical nutrition · 2017

  70. 0.53

    Dementia risk across distinct metabolic profiles in the UK Biobank

    Lumsden AL, Mulugeta A, Hypponen E · GeroScience · 2026

03cerebrospinal fluid · csf68편

  1. 0.88

    Plasma lipidomics in women with Alzheimer's disease: Exploring associations with ApoE genotype and cardiovascular risk

    Ferre-Gonzalez L, Pena-Bautista C, Alvarez-Sanchez L et al. · Journal of clinical lipidology · 2026

  2. 0.87

    The Effect of APOE epsilon4 on Alzheimer's Disease Fluid Biomarkers: A Cross-Sectional Study Based on the COAST

    Zhao B, Zang P, Quan M et al. · CNS neuroscience & therapeutics · 2025

  3. 0.87

    APOE epsilon4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease

    Abdullah L, Evans JE, Emmerich T et al. · Aging · 2017

  4. 0.86

    Plasma apolipoprotein E levels, isoform composition, and dimer profile in relation to plasma lipids in racially diverse patients with Alzheimer's disease and mild cognitive impairment

    Giannisis A, Al-Grety A, Carlsson H et al. · Alzheimer's research & therapy · 2023

  5. 0.85

    Influence of APOE4 genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum

    Papotti B, Palumbo M, Adorni MP et al. · Journal of Alzheimer's disease : JAD · 2024

  6. 0.85

    Metabolomics study to identify plasma biomarkers in alzheimer disease: ApoE genotype effect

    Pena-Bautista C, Roca M, Lopez-Cuevas R et al. · Journal of pharmaceutical and biomedical analysis · 2020

  7. 0.83

    Serum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers

    Bernath MM, Bhattacharyya S, Nho K et al. · Neurology · 2020

  8. 0.83

    APOE epsilon4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain

    Huguenard CJC, Cseresznye A, Evans JE et al. · Current research in translational medicine · 2023

  9. 0.82

    Differences in plasma metabolites related to Alzheimer's disease, APOE epsilon4 status, and ethnicity

    Vardarajan B, Kalia V, Manly J et al. · Alzheimer's & dementia (New York, N. Y.) · 2020

  10. 0.82

    Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease

    Papassotiropoulos A, Lutjohann D, Bagli M et al. · Neuroreport · 2000

  11. 0.80

    Predictive metabolic networks reveal sex- and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer's disease

    Chang R, Trushina E, Zhu K et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  12. 0.79

    Associations of ApoE4 status and DHA supplementation on plasma and CSF lipid profiles and entorhinal cortex thickness

    Bantugan MA, Xian H, Solomon V et al. · Journal of lipid research · 2023

  13. 0.79

    Hippocampal mediation in the lipid-Alzheimer's disease pathway: A high-dimensional mediation analysis stratified by APOE and sex

    Cao Y, Fan Y, Meng Q et al. · Alzheimer's & dementia (New York, N. Y.) · 2026

  14. 0.79

    Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of APOE4 Homozygotes and Non-APOE4 Carriers with Mild Cognitive Impairment versus Subjective Cognitive Decline

    den Hoedt S, Dorst-Lagerwerf KY, de Vries HE et al. · Journal of Alzheimer's disease reports · 2023

  15. 0.79

    Machine learning models of Alzheimer's disease spectrum using blood tests

    Falasca NW, Ferretti A, Granzotto A et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2025

  16. 0.78

    Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics

    Han X, Rozen S, Boyle SH et al. · PloS one · 2011

  17. 0.77

    S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease

    Linnebank M, Popp J, Smulders Y et al. · Neuro-degenerative diseases · 2010

  18. 0.77

    One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond

    Dayon L, Guiraud SP, Corthesy J et al. · Alzheimer's research & therapy · 2017

  19. 0.76

    Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls

    Martinez-Morillo E, Hansson O, Atagi Y et al. · Acta neuropathologica · 2014

  20. 0.75

    APOE Genotype Differentially Modulates Plasma Lipids in Healthy Older Individuals, with Relevance to Brain Health

    Wong MWK, Braidy N, Crawford J et al. · Journal of Alzheimer's disease : JAD · 2019

  21. 0.75

    APOE epsilon2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies

    Wang T, Huynh K, Giles C et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022

  22. 0.74

    Targeted serum metabolomic profiling and machine learning approach in Alzheimer's disease using the Alzheimer's disease diagnostics clinical study (ADDIA) cohort

    Mukesha D, Sarter M, Dubray M et al. · Journal of Alzheimer's disease : JAD · 2025

  23. 0.72

    Simultaneous Mass Spectrometry-Based Apolipoprotein Profiling and Apolipoprotein E Phenotyping in Patients with ASCVD and Mild Cognitive Impairment

    Begcevic Brkovic I, Zohrer B, Scholz M et al. · Nutrients · 2022

  24. 0.72

    Dynamic functional network connectivity and its association with lipid metabolism in Alzheimer's disease

    Zang F, Liu X, Fan D et al. · CNS neuroscience & therapeutics · 2024

  25. 0.71

    Blood PCSK9 Impacts Alzheimer's Disease Risk in an APOE Genotype-Dependent Manner: A Prospective Cohort Study

    Tao Q, Ang TFA, Huang J et al. · Health science reports · 2026

  26. 0.69

    Integrating large-scale serum metabolomics and APOE epsilon4 genotype status for the non-invasive detection of Alzheimer's disease in the ADNI cohort

    Mukesha D, Firat H, Sacco G · medRxiv : the preprint server for health sciences · 2026

  27. 0.68

    Lipidomic Network of Mild Cognitive Impairment from the Mayo Clinic Study of Aging

    Wang X, Bui H, Vemuri P et al. · Journal of Alzheimer's disease : JAD · 2021

  28. 0.68

    Transfer learning reveals the mediating mechanisms of cross-ethnic lipid metabolic pathways in the association between APOE gene and Alzheimer's disease

    Pan L, Liu Y, Huang C et al. · Briefings in bioinformatics · 2025

  29. 0.67

    Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Abeta40/42 Ratio as a Biomarker of Amyloid-beta Amyloidosis in Alzheimer's Disease

    Nakamura T, Kawarabayashi T, Ueda T et al. · Journal of Alzheimer's disease : JAD · 2023

  30. 0.67

    LOESS-based normalization workflow for targeted HDL glycoproteomics in an Alzheimer's disease cohort

    Hong BV, Liu Y, Oloumi A et al. · RSC advances · 2026

  31. 0.67

    Fast autoregressive model for multivariate dependent outcomes with application to lipidomics analysis for Alzheimer's disease and APOE-epsilon4

    Lee H, Ye Z, Chen C et al. · Computational statistics & data analysis · 2026

  32. 0.66

    Blood-based metabolic signatures in Alzheimer's disease

    de Leeuw FA, Peeters CFW, Kester MI et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2017

  33. 0.66

    A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI

    O'Bryant SE, Xiao G, Barber R et al. · PloS one · 2011

  34. 0.66

    Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease

    Bowman GL, Kaye JA, Quinn JF · Current gerontology and geriatrics research · 2012

  35. 0.66

    Beyond Lipidation: CSF APOE4 Protein Burden, Not HDL Subclass, Drives Tau Associations in APOE4 Alzheimer's Disease

    Tsokolas ZE, Asante I, Tsiknia AA et al. · Research square · 2026

  36. 0.66

    Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer's disease-finding from Alzheimer's Disease Neuroimaging Initiative

    Borkowski K, Yin C, Kindt A et al. · Alzheimer's research & therapy · 2026

  37. 0.65

    Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer's Disease Spectrum

    Nilsson NIV, Picard C, Labonte A et al. · Genes · 2021

  38. 0.64

    Alzheimer's disease polygenic risk's association with all-cause dementia through the plasma metabolome in the UK Biobank study

    Beydoun MA, Hu YH, Li Z et al. · GeroScience · 2025

  39. 0.62

    Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease

    Shi L, Xu J, Green R et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  40. 0.62

    Deep learning analysis of UPLC-MS/MS-based metabolomics data to predict Alzheimer's disease

    Wang K, Theeke LA, Liao C et al. · Journal of the neurological sciences · 2023

  41. 0.62

    Prospective study on association between plasma amyloid beta-42 and atherosclerotic risk factors

    Blasko I, Kemmler G, Jungwirth S et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2011

  42. 0.62

    Association Between Plasma Metabolomic Profile and Machine Learning-Based Brain Age

    Li Y, Wang J, Miao Y et al. · Aging cell · 2025

  43. 0.61

    Metabolic Alteration in Oxylipins and Endocannabinoids Point to an Important Role for Soluble Epoxide Hydrolase and Inflammation in Alzheimer's Disease - Finding from Alzheimer's Disease Neuroimaging Initiative

    Borkowski K, Yin C, Kindt A et al. · bioRxiv : the preprint server for biology · 2025

  44. 0.61

    Assessment of Screening Approach in Early and Differential Alzheimer's Disease Diagnosis

    Ferre-Gonzalez L, Pena-Bautista C, Alvarez-Sanchez L et al. · Antioxidants (Basel, Switzerland) · 2021

  45. 0.61

    Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results

    Roubaud-Baudron C, Krolak-Salmon P, Quadrio I et al. · Neurobiology of aging · 2012

  46. 0.61

    Serum Lipidome as an Early Peripheral Indicator in Familial Alzheimer's Disease

    Cardona-Gomez GP, Salomon-Cruz ID, Lozano-Trujillo LA et al. · bioRxiv : the preprint server for biology · 2025

  47. 0.60

    Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease

    Johansson P, Almqvist EG, Johansson JO et al. · PloS one · 2013

  48. 0.60

    Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease

    Davidson MH, Szarek M, Scheltens P et al. · The journal of prevention of Alzheimer's disease · 2026

  49. 0.60

    Circulating lipids uncover early membrane disruption as a primary event preceding Alzheimer's disease onset

    Cardona-Gomez GP, Salomon-Cruz ID, Galvis-Garrido ND et al. · Research square · 2026

  50. 0.59

    Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer's disease

    Laffoon SB, Doecke JD, Roberts AM et al. · Proteome science · 2022

  51. 0.59

    Proteomic analysis of APOEepsilon4 carriers implicates lipid metabolism, complement and lymphocyte signaling in cognitive resilience

    Walker KA, An Y, Moghekar A et al. · Molecular neurodegeneration · 2024

  52. 0.59

    Health-related factors and their impact on blood-based biomarkers of Alzheimer's disease

    Kurz C, Taute M, Tegethoff P et al. · Aging brain · 2026

  53. 0.58

    Hypolipidemics reduce the rate of Alzheimer's disease development and dementia progression: A cohort study linked with genetic and neuropathological analyses

    Sternberg Z, Podolsky RE, Yu J et al. · The journal of prevention of Alzheimer's disease · 2026

  54. 0.57

    A leakage-controlled multi-compartment benchmark of fluid biomarkers for predicting mild cognitive impairment to Alzheimer's disease conversion: plasma, CSF, and high-plex omics in a single cohort

    Cangas Caiza IJ · Research square · 2026

  55. 0.57

    Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer's Disease

    Sakr F, Dyrba M, Brauer A et al. · Journal of Alzheimer's disease : JAD · 2022

  56. 0.57

    The small HDL particle hypothesis of Alzheimer's disease

    Martinez AE, Weissberger G, Kuklenyik Z et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  57. 0.56

    The C677T variant in MTHFR modulates associations between blood-based and cerebrospinal fluid biomarkers of neurodegeneration

    Roussotte FF, Narr KL, Small GW et al. · Neuroreport · 2016

  58. 0.56

    Life course plasma metabolomic signatures of genetic liability to Alzheimer's disease

    Compton H, Smith ML, Bull C et al. · Scientific reports · 2024

  59. 0.55

    Associations between serum metabolic syndrome indicators levels and cerebrospinal fluid pathological protein in dementia and pre-dementia patients

    Ding J, Quan M, Zang P et al. · Journal of Alzheimer's disease : JAD · 2025

  60. 0.53

    Effect of simvastatin on CSF Alzheimer disease biomarkers in cognitively normal adults

    Li G, Mayer CL, Morelli D et al. · Neurology · 2017

  61. 0.52

    APOE genotype and brain amyloid are associated with changes in the plasma proteome in elderly subjects without dementia

    Philippi SM, Bp K, Raj T et al. · Annals of clinical and translational neurology · 2025

  62. 0.52

    Peripheral blood biomarkers RCAN1, Clusterin, RAGE, and malondialdehyde for early diagnosis and progression of Alzheimer's disease

    Roman-Dominguez A, Mas-Bargues C, Perez V et al. · BMC medicine · 2026

  63. 0.51

    Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease

    Johansson P, Almqvist EG, Bjerke M et al. · Journal of Alzheimer's disease : JAD · 2017

  64. 0.51

    Correlations between the NMR Lipoprotein Profile, APOE Genotype, and Cholesterol Efflux Capacity of Fasting Plasma from Cognitively Healthy Elderly Adults

    de Rojas I, Del Barrio L, Hernandez I et al. · International journal of molecular sciences · 2023

  65. 0.51

    Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's disease

    Xu J, Bankov G, Kim M et al. · Translational neurodegeneration · 2020

  66. 0.50

    Cerebrospinal fluid tau protein and periventricular white matter lesions in patients with mild cognitive impairment: implications for 2 major pathways

    Maruyama M, Matsui T, Tanji H et al. · Archives of neurology · 2004

  67. 0.50

    The Association of Essential Metals with APOE Genotype in Alzheimer's Disease

    Babic Leko M, Jurasovic J, Nikolac Perkovic M et al. · Journal of Alzheimer's disease : JAD · 2021

  68. 0.50

    Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial

    Hanson AJ, Bayer-Carter JL, Green PS et al. · JAMA neurology · 2013

04polymorphism · allele52편

  1. 0.91

    Gene dose effect of the APOE-epsilon4 allele on plasma HDL cholesterol level in patients with Alzheimer's disease

    Hoshino T, Kamino K, Matsumoto M · Neurobiology of aging · 2002

  2. 0.90

    The diagnostic value investigation of blood lipid as biomarker combined with apolipoprotein E genotype in dementia with Lewy bodies

    Di C, Tang T, Wu H et al. · Journal of Alzheimer's disease : JAD · 2026

  3. 0.89

    The sex-specific effect of the apolipoprotein E allele and methylenetetrahydrofolate reductase gene polymorphism on the biochemical, anatomical, and cognitive profiles of patients clinically diagnosed with probable Alzheimer's disease

    Kim HJ, Park J, Kim YS et al. · International journal of geriatric psychiatry · 2021

  4. 0.87

    Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment

    Religa D, Styczynska M, Peplonska B et al. · Dementia and geriatric cognitive disorders · 2003

  5. 0.86

    Association between apolipoprotein E gene polymorphisms and serum lipid indicators and Alzheimer's disease risk

    Chen H, Zhang H, Yang M et al. · Journal of Alzheimer's disease : JAD · 2026

  6. 0.86

    APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk

    Borroni B, Grassi M, Costanzi C et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2006

  7. 0.86

    Serum lipoprotein profile and APOE genotype in Alzheimer's disease

    Cagnin A, Zambon A, Zarantonello G et al. · Journal of neural transmission. Supplementum · 2007

  8. 0.86

    Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease

    Anello G, Gueant-Rodriguez RM, Bosco P et al. · Neuroreport · 2004

  9. 0.85

    Association between genetic and environmental factors and the risk of Alzheimer's disease

    Styczynska M, Strosznajder JB, Religa D et al. · Folia neuropathologica · 2008

  10. 0.85

    Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study

    Jarvik GP, Wijsman EM, Kukull WA et al. · Neurology · 1995

  11. 0.85

    A cross-sectional study of inpatients with late stage of dementia in Southeast China and the associations between biochemical parameters and apolipoprotein E genotypes

    Jiang B, Zhang XP, Chen MF et al. · Clinical interventions in aging · 2018

  12. 0.84

    Apolipoprotein E epsilon4 allele and malondialdehyde level are independent risk factors for Alzheimer's disease

    Lopez-Riquelme N, Alom-Poveda J, Viciano-Morote N et al. · SAGE open medicine · 2016

  13. 0.83

    Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans

    Evans RM, Emsley CL, Gao S et al. · Neurology · 2000

  14. 0.83

    Effects of apolipoprotein E genotype on blood lipid composition and membrane platelet fluidity in Alzheimer's disease

    Fernandes MA, Proenca MT, Nogueira AJ et al. · Biochimica et biophysica acta · 1999

  15. 0.82

    Apolipoprotein E-4 gene dose in clinically diagnosed Alzheimer's disease: prevalence, plasma cholesterol levels and cerebrovascular change

    Czech C, Forstl H, Hentschel F et al. · European archives of psychiatry and clinical neuroscience · 1994

  16. 0.82

    Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer's Disease

    Zverova M, Kitzlerova E, Fisar Z et al. · Current Alzheimer research · 2018

  17. 0.82

    Studies on the effect of the apolipoprotein E genotype on the lipid profile in Alzheimer's disease

    Sabbagh MN, Sandhu S, Kolody H et al. · Current Alzheimer research · 2006

  18. 0.81

    Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients

    Lutjohann D, Papassotiropoulos A, Bjorkhem I et al. · Journal of lipid research · 2000

  19. 0.80

    Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease

    Solfrizzi V, Panza F, D'Introno A et al. · Journal of neurology, neurosurgery, and psychiatry · 2002

  20. 0.79

    Effects of APOE rs429358, rs7412 and GSTM1/GSTT1 Polymorphism on Plasma and Erythrocyte Antioxidant Parameters and Cognition in Old Chinese Adults

    Yuan L, Liu J, Dong L et al. · Nutrients · 2015

  21. 0.78

    Lipid metabolism parameters in patients with Alzheimer's disease and their first degree relatives

    Czyzewski K, Lalowski MM, Pfeffer A et al. · Acta neurobiologiae experimentalis · 2001

  22. 0.77

    Apolipoprotein E as vascular risk factor in neurodegenerative dementia

    Folin M, Baiguera S, Conconi MT et al. · International journal of molecular medicine · 2004

  23. 0.76

    Cognitive functions, lipid profile, and Apolipoprotein E gene polymorphism in postmenopausal women

    Bojar I, Owoc J, Wojcik-Fatla A et al. · Annals of agricultural and environmental medicine : AAEM · 2015

  24. 0.75

    OxLDL plasma levels in patients with Alzheimer's disease

    Grossi MF, Carvalho MdG, Silveira JN et al. · Arquivos de neuro-psiquiatria · 2018

  25. 0.72

    Methylenetetrahydrofolate reductase gene and risk of Alzheimer's disease in Koreans

    Kim JM, Stewart R, Kim SW et al. · International journal of geriatric psychiatry · 2008

  26. 0.72

    Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians

    Panza F, Solfrizzi V, Colacicco AM et al. · Neuroreport · 2003

  27. 0.71

    Plasma apolipoproteins and physical and cognitive health in very old individuals

    Muenchhoff J, Song F, Poljak A et al. · Neurobiology of aging · 2017

  28. 0.70

    APOE epsilon4 Carriers Have a Greater Propensity to Glycation and sRAGE Which Is Further Influenced by RAGE G82S Polymorphism

    Deo P, Dhillon VS, Chua A et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2020

  29. 0.69

    Decreased plasma C-reactive protein levels in APOE epsilon4 allele carriers

    Martiskainen H, Takalo M, Solomon A et al. · Annals of clinical and translational neurology · 2018

  30. 0.69

    Allelic Distribution of Genes for Apolipoprotein E and MTHFR in Patients with Alzheimer's Disease and Their Epistatic Interaction

    Sutovsky S, Petrovic R, Fischerova M et al. · Journal of Alzheimer's disease : JAD · 2020

  31. 0.68

    The Association Between Plasma alpha-Synuclein (alpha-syn) Protein, Urinary Alzheimer-Associated Neuronal Thread Protein (AD7c-NTP), and Apolipoprotein Epsilon 4 (ApoE epsilon4) Alleles and Cognitive Decline in 60 Patients with Alzheimer's Disease Compared with 28 Age-Matched Normal Individuals

    Lv S, Zhou X, Li Y et al. · Medical science monitor : international medical journal of experimental and clinical research · 2021

  32. 0.68

    Phenome-wide association of APOE alleles in the All of Us Research Program

    Khajouei E, Ghisays V, Piras IS et al. · EBioMedicine · 2025

  33. 0.67

    Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men

    Plourde M, Vohl MC, Vandal M et al. · The British journal of nutrition · 2009

  34. 0.66

    Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB

    Wingo TS, Cutler DJ, Wingo AP et al. · JAMA neurology · 2019

  35. 0.64

    A pilot study of gene/gene and gene/environment interactions in Alzheimer disease

    Ghebranious N, Mukesh B, Giampietro PF et al. · Clinical medicine & research · 2011

  36. 0.62

    The Methylenetetrahydrofolate Reductase C677T Polymorphism and Risk for Late-Onset Alzheimer's disease: Further Evidence in an Italian Multicenter Study

    Stoccoro A, Tannorella P, Salluzzo MG et al. · Journal of Alzheimer's disease : JAD · 2017

  37. 0.61

    Phenome-Wide Association of APOE Alleles in the All of Us Research Program

    Khajouei E, Ghisays V, Piras IS et al. · medRxiv : the preprint server for health sciences · 2024

  38. 0.59

    Associations between selected genetic variants and lipid profile variability in response to statins in Alzheimer's disease: a prospective observational study

    Oliveira FFd, Almeida SSd, Chen ES et al. · Sao Paulo medical journal = Revista paulista de medicina · 2025

  39. 0.59

    Alzheimer's Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N = 395,769)

    Ferguson AC, Tank R, Lyall LM et al. · Journal of Alzheimer's disease : JAD · 2020

  40. 0.57

    Metabolic Overlap between Alzheimer's Disease and Metabolic Syndrome Identifies the PVRL2 Gene as a New Modulator of Diabetic Dyslipidemia

    Guardiola M, Muntane G, Martinez I et al. · International journal of molecular sciences · 2023

  41. 0.56

    PEMT G523A (V175M) is associated with sporadic Alzheimer's disease in a Chinese population

    Bi XH, Zhao HL, Zhang ZX et al. · Journal of molecular neuroscience : MN · 2012

  42. 0.56

    Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population

    Stewart R, Russ C, Richards M et al. · Dementia and geriatric cognitive disorders · 2001

  43. 0.56

    Atheromatosis extent in coronary artery disease is not correlated with apolipoprotein-E polymorphism and its plasma levels, but associated with cognitive decline

    Lima LM, Carvalho MdG, Ferreira CN et al. · Current Alzheimer research · 2010

  44. 0.55

    Cholesteryl ester transfer protein genotype modifies the effect of apolipoprotein epsilon4 on memory decline in older adults

    Sundermann EE, Wang C, Katz M et al. · Neurobiology of aging · 2016

  45. 0.54

    LDL density and oxidation are modulated by PON1 promoter genotype in patients with Alzheimer's disease

    Cagnin A, Leon A, Vianello D et al. · Journal of Alzheimer's disease : JAD · 2013

  46. 0.54

    Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease?

    Chouinard-Watkins R, Plourde M · Nutrients · 2014

  47. 0.54

    Polymorphisms of the apolipoprotein E gene regulatory region and of the LDL receptor gene in late-onset Alzheimer's disease in relation to the plasma lipidic pattern

    Scacchi R, Gambina G, Martini MC et al. · Dementia and geriatric cognitive disorders · 2001

  48. 0.53

    Association of MTHFR gene polymorphism C677T with susceptibility to late-onset Alzheimer's disease

    Wang B, Jin F, Kan R et al. · Journal of molecular neuroscience : MN · 2005

  49. 0.52

    Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease?

    Sparks DL · Annals of the New York Academy of Sciences · 1997

  50. 0.51

    Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary

    Kovacs KA, Pamer Z, Kovacs A et al. · Ideggyogyaszati szemle · 2007

  51. 0.50

    Biothiols and oxidative stress markers and polymorphisms of TOMM40 and APOC1 genes in Alzheimer's disease patients

    Prendecki M, Florczak-Wyspianska J, Kowalska M et al. · Oncotarget · 2018

  52. 0.50

    Selected LDLR and APOE Polymorphisms Affect Cognitive and Functional Response to Lipophilic Statins in Alzheimer's Disease

    de Oliveira FF, Chen ES, Smith MC et al. · Journal of molecular neuroscience : MN · 2020

05white matter · imaging47편

  1. 0.90

    High-Density Lipoprotein Changes in Alzheimer's Disease Are APOE Genotype-Specific

    Hong BV, Zheng J, Agus JK et al. · Biomedicines · 2022

  2. 0.89

    Impact of APOE epsilon4 Genotype Load on Cognitive Function and Lipid Metabolism in Patients With Cerebral Small Vessel Disease

    Jin T, Yang H, Liu F et al. · Annals of clinical and translational neurology · 2026

  3. 0.88

    Effect of APOE epsilon4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease

    Morris JK, Uy RAZ, Vidoni ED et al. · Journal of Alzheimer's disease : JAD · 2017

  4. 0.86

    APOE4 allele-specific associations between diet, multimodal biomarkers, and cognition among Puerto Rican adults in Massachusetts

    Guan Y, Cheng CH, Bellomo LI et al. · Frontiers in aging neuroscience · 2023

  5. 0.86

    Vascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum

    Lorius N, Locascio JJ, Rentz DM et al. · Alzheimer disease and associated disorders · 2015

  6. 0.84

    The relationship of cardiovascular risk factors to Alzheimer disease in Choctaw Indians

    Weiner MF, Hynan LS, Rossetti H et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2011

  7. 0.84

    Vitamin D Levels, APOE Allele, and MRI Volumetry Assessed by NeuroQuant in Norwegian Adults with Cognitive Symptoms

    Soares JZ, Pettersen R, Benth JS et al. · Journal of Alzheimer's disease : JAD · 2021

  8. 0.84

    Apolipoprotein E genotype modulates effects of vitamin B12 and homocysteine on grey matter volume in Alzheimer's disease

    Lee YM, Ha JK, Park JM et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2016

  9. 0.84

    Increased vulnerability to low-density lipoprotein cholesterol in apolipoprotein E4-positive females: Longitudinal effects on neurodegeneration and cognition

    Tayem AJ, Jaber AB, Altantawi AM et al. · Journal of Alzheimer's disease : JAD · 2026

  10. 0.84

    Elevated blood glucose levels are associated with the progression of brain hypometabolism, and HDL-C and APOE4 add to this association

    Rajendrakumar AL, Ukraintseva S, Bagley O et al. · medRxiv : the preprint server for health sciences · 2024

  11. 0.82

    APOE4 poses opposite effects of plasma LDL on white matter integrity in older adults

    Ye Z, Pan Y, McCoy RG et al. · bioRxiv : the preprint server for biology · 2023

  12. 0.82

    Apolipoprotein E4 Mediates the Association Between Midlife Dyslipidemia and Cerebral Amyloid in Aging Women

    Szoeke C, Goodwill AM, Gorelik A et al. · Journal of Alzheimer's disease : JAD · 2019

  13. 0.81

    Liver-metabolic stress, apolipoprotein E epsilon4, and cognition and amyloid burden: findings from the dementia platform Korea trial-ready registry

    Ahn YH, Kang JG, Choi D et al. · Frontiers in aging neuroscience · 2026

  14. 0.80

    The influence of blood lipids on cerebral perfusion by apolipoprotein E status

    Decker KP, Rizzi NA, Rigas Z et al. · Journal of lipid research · 2026

  15. 0.79

    The blood lipidome fatty acid profile predicts the disease risk and clinical phenotypes of Alzheimer's disease: associations from two prospective cohort studies

    Liu WZ, Huang LY, Chi S et al. · Translational psychiatry · 2025

  16. 0.76

    The Value of Brain Structural Magnetic Resonance Imaging Combined with APOE--epsilon4 Genotype in Early Diagnosis and Disease Progression of Senile Vascular Cognitive Impairment No Dementia

    Zhao W, Yin C, Yu F et al. · Contrast media & molecular imaging · 2022

  17. 0.76

    Apolipoprotein E4 Moderates the Association Between Vascular Risk Factors and Brain Pathology

    Kaufman CS, Morris JK, Vidoni ED et al. · Alzheimer disease and associated disorders · 2021

  18. 0.75

    Triglycerides are negatively correlated with cognitive function in nondemented aging adults

    Parthasarathy V, Frazier DT, Bettcher BM et al. · Neuropsychology · 2017

  19. 0.74

    Plasma high-density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume

    Pedrini S, Doecke JD, Hone E et al. · Journal of neurochemistry · 2022

  20. 0.72

    Antioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementia

    Zito G, Polimanti R, Panetta V et al. · Rejuvenation research · 2013

  21. 0.72

    LDL cholesterol is associated with higher AD neuropathology burden independent of APOE

    Wingo AP, Vattathil SM, Liu J et al. · Journal of neurology, neurosurgery, and psychiatry · 2022

  22. 0.71

    Free-water imaging of the nucleus basalis of Meynert in apolipoprotein E4 carriers

    Ofori E, Braden BB, Chen K et al. · Frontiers in aging neuroscience · 2025

  23. 0.71

    Sex and APOE4-specific links between cardiometabolic risk factors and white matter alterations in individuals with a family history of Alzheimer's disease

    Tremblay SA, Nathan Spreng R, Wearn A et al. · Neurobiology of aging · 2025

  24. 0.69

    Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease

    Solomon A, Leoni V, Kivipelto M et al. · Neuroscience letters · 2009

  25. 0.68

    Homocysteine, white matter hyperintensities, and cognition in healthy elderly people

    Dufouil C, Alperovitch A, Ducros V et al. · Annals of neurology · 2003

  26. 0.66

    Interaction of APOE e4 and poor glycemic control predicts white matter hyperintensity growth from 73 to 76

    Cox SR, Ritchie SJ, Dickie DA et al. · Neurobiology of aging · 2017

  27. 0.66

    Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging

    Reiman EM, Chen K, Langbaum JBS et al. · NeuroImage · 2010

  28. 0.66

    Lipid profile components and subclinical cerebrovascular disease in the northern Manhattan study

    Willey JZ, Gardener H, Moon YP et al. · Cerebrovascular diseases (Basel, Switzerland) · 2014

  29. 0.65

    Rapamycin enhances neurovascular, peripheral metabolic, and immune function in cognitively normal, middle-aged APOE4 Carriers: genotype-dependent effects compared to non-carriers

    Lin AL, Aware C, Neher C et al. · Research square · 2025

  30. 0.65

    Associations between white matter lesions, cerebrovascular risk factors, and low CSF Abeta42

    Stenset V, Johnsen L, Kocot D et al. · Neurology · 2006

  31. 0.64

    Apolipoprotein E varepsilon4 allele has an impact on vascular reactivity in Alzheimer's disease

    Algotsson A, Nordberg A, Winblad B · Archives of gerontology and geriatrics · 2000

  32. 0.64

    ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy

    Montanola A, de Retana SF, Lopez-Rueda A et al. · Neuromolecular medicine · 2016

  33. 0.62

    Atherosclerosis risk factors in American Indians with Alzheimer disease: preliminary findings

    Weiner MF, Rosenberg RN, Womack KB et al. · Alzheimer disease and associated disorders · 2008

  34. 0.60

    Impact of sex and APOE epsilon4 on age-related cerebral perfusion trajectories in cognitively asymptomatic middle-aged and older adults: A longitudinal study

    Wang R, Oh JM, Motovylyak A et al. · Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021

  35. 0.59

    Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study

    Matsuzaki T, Sasaki K, Tanizaki Y et al. · Neurology · 2010

  36. 0.58

    Metabolic syndrome marks early risk for cognitive decline with APOE4 gene variation: A case study

    Brown D, Gibas KJ · Diabetes & metabolic syndrome · 2018

  37. 0.58

    Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults

    Ward MA, Bendlin BB, McLaren DG et al. · Frontiers in aging neuroscience · 2010

  38. 0.57

    The effect of midlife cardiovascular risk factors on white matter hyperintensity volume and cognition two decades later in normal ageing women

    Aljondi R, Szoeke C, Steward C et al. · Brain imaging and behavior · 2020

  39. 0.56

    In silico metabolic modelling links microbiome-derived metabolites to risk factors of Alzheimer's disease

    Hensen T, Ahmad S, Kastenmuller G et al. · Gut microbes reports · 2025

  40. 0.55

    Insulin resistance and body mass index are associated with TSPO PET in cognitively unimpaired elderly

    Ekblad LL, Tuisku J, Koivumaki M et al. · Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023

  41. 0.54

    Physical activity and amyloid-beta plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing

    Brown BM, Peiffer JJ, Taddei K et al. · Molecular psychiatry · 2013

  42. 0.53

    Acute cerebral blood flow response to heavy cream ingestion in older adults: A non-randomized pilot study

    Ashford NK, Rane S, Farris KM et al. · Journal of Alzheimer's disease : JAD · 2025

  43. 0.53

    Is late-life vulnerability to cardiovascular disease risk associated with longitudinal tau accumulation in older adults with mild cognitive impairment?

    Dratva MA, Diaz JM, Thomas ML et al. · JAR life · 2025

  44. 0.53

    Apolipoprotein E epsilon4 allele, skin vessel reactivity and vascular risk factors in Alzheimer's disease

    Algotsson A, Nordberg A, Lannfelt L et al. · Archives of gerontology and geriatrics · 1996

  45. 0.52

    The impact of glucose disorders on cognition and brain volumes in the elderly: the Sydney Memory and Ageing Study

    Samaras K, Lutgers HL, Kochan NA et al. · Age (Dordrecht, Netherlands) · 2014

  46. 0.51

    Association of Cardiovascular and Alzheimer's Disease Risk Factors with Intracranial Arterial Blood Flow in Whites and African Americans

    Clark LR, Norton D, Berman SE et al. · Journal of Alzheimer's disease : JAD · 2019

  47. 0.51

    APOE4 and age affect the brain entorhinal cortex structure and blood arachidonic acid and docosahexaenoic acid levels after mild TBI

    Aldrich G, Evans JE, Davis R et al. · Scientific reports · 2024

06mice · human8편

  1. 0.71

    Homocysteine, another risk factor for Alzheimer disease, impairs apolipoprotein E3 function

    Minagawa H, Watanabe A, Akatsu H et al. · The Journal of biological chemistry · 2010

  2. 0.68

    Apolipoprotein E4 interferes with lipid metabolism to exacerbate depression-like behaviors in 5xFAD mice

    Gong Y, Li M, Liu M et al. · Animal models and experimental medicine · 2024

  3. 0.66

    APOE epsilon4 is associated with higher vitamin D levels in targeted replacement mice and humans

    Huebbe P, Nebel A, Siegert S et al. · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2011

  4. 0.57

    Bioenergetic and inflammatory systemic phenotypes in Alzheimer's disease APOE epsilon4-carriers

    Wilkins HM, Wang X, Menta BW et al. · Aging cell · 2021

  5. 0.57

    Therapeutic Effects of the Traditional Chinese Formula Qifuyin on Cognition, Lipid Metabolism, and Gut Microbiota in ApoE4 Mice

    Yu Y, Zhao H, He Y et al. · Combinatorial chemistry & high throughput screening · 2026

  6. 0.52

    Alzheimer's Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways

    Zhao N, Ren Y, Yamazaki Y et al. · Neuron · 2020

  7. 0.51

    APOE4 Exacerbates Cerebral Tau Pathology Through Cholesterol-Induced Degradation of Phosphatase in Atherosclerosis

    Ding J, Sun B, Gao Y et al. · CNS neuroscience & therapeutics · 2025

  8. 0.50

    High-fat Western diet induces retinal and metabolic alterations in APOE3 and APOE4 knock-in mice

    Abhyankar SD, Luo Q, Hartman GD et al. · Scientific reports · 2026

07review · therapeutic6편

  1. 0.81

    Functional Vitamin E deficiency in ApoE4 patients with Alzheimer's disease

    Mas E, Dupuy AM, Artero S et al. · Dementia and geriatric cognitive disorders · 2006

  2. 0.68

    APOE-stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's Disease

    Li F, Chen Y, Western D et al. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026

  3. 0.67

    Ageing related thyroid deficiency increases brain-targeted transport of liver-derived ApoE4-laden exosomes leading to cognitive impairment

    Zhang M, Gong W, Zhang D et al. · Cell death & disease · 2022

  4. 0.59

    Peripheral metabolism of lipoprotein-amyloid beta as a risk factor for Alzheimer's disease: potential interactive effects of APOE genotype with dietary fats

    D'Alonzo ZJ, Lam V, Takechi R et al. · Genes & nutrition · 2023

  5. 0.57

    The role of insulin resistance and APOE genotype on blood-brain barrier integrity in Alzheimer's disease

    Padovani A, Galli A, Bazzoli E et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  6. 0.57

    Impaired Oxidative Stress Markers and Activities of Matrix Metalloproteinases in Plasma of Patients with Alzheimer's Disease, Emphasizing Sex and APOE epsilon4 Allele Possession

    Radosinska D, Kollarova M, Shawkatova I et al. · International journal of molecular sciences · 2025

08apoe4 · protein2편

  1. 0.75

    Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels

    Kuo YM, Emmerling MR, Bisgaier CL et al. · Biochemical and biophysical research communications · 1998

  2. 0.67

    Pravastatin at 10 mg/day does not decrease plasma levels of either amyloid-beta (Abeta) 40 or Abeta 42 in humans

    Ishii K, Tokuda T, Matsushima T et al. · Neuroscience letters · 2003